Potential application of nanodelivery systems targeting ELAVL1 in prostate cancer treatment
{{output}}
Introduction: Prostate cancer (PCa) is one of the most common malignant tumors in men, with increasing incidence and mortality rates, and its treatment still faces many challenges and unmet needs. ELAVL1 (human antigen R, HuR) is... ...
